title: P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature.
abstract: During the past few decades, researchers have been looking for parameters with an impact on the prognosis of patients with astrocytic tumors. p53 is one of the most widely investigated molecules in human gliomas. We aimed to comprehensively review the evidence for the prognostic usefulness of p53 immunohistochemical expression in paraffin-embedded tissue specimens from diffusely infiltrating astrocytomas. We conducted a systematic review of the PubMed database through December 2007 to identify cohort studies that evaluated p53 immunohistochemical expression as a prognostic marker for human astrocytomas. Estimates of significance were extracted from association tests and hazard ratios with 95% CI from actuarial curves and Cox regression analyses. A meta-analysis was performed on the studies that applied Cox models and had adjusted the hazard ratio of p53 expression with tumor grade and patients' age. We reviewed 44 publications (including 3,627 patients), 14 of which included the estimates (HR and 95% CI) derived from Cox regression. Descriptive analysis showed that most of the published articles did not contain information on important variables such as sex and age (missing from 25% and 11% of studies, respectively), previous treatment, tissue-retrieval and follow-up period (56%). The quantitative synthesis showed that p53 expression is not a significant prognostic factor (combined HR = 1.034, P = 0.531). There was no significant between-study heterogeneity and publication bias. A second meta-analysis performed only on glioblastomas showed that the overall risk of mortality in these tumors was -0.123 (-0.346 to 0.100) and was not statistically significant. After almost 20 years of research, published evidence does not substantiate the usefulness of p53 immunohistochemical expression as a prognostic marker in patients with astrocytic neoplasms.
authors.affiliation: Medical School, Department of Pathology, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece. glevidou@yahoo.gr
authors.forename: Georgia
authors.initials: G
authors.lastname: Levidou
authors.forename: Elias
authors.initials: E
authors.lastname: El-Habr
authors.forename: Angelica A
authors.initials: AA
authors.lastname: Saetta
authors.forename: Christine
authors.initials: C
authors.lastname: Bamias
authors.forename: Klea
authors.initials: K
authors.lastname: Katsouyanni
authors.forename: Klea
authors.initials: K
authors.lastname: Katsougiannis
authors.forename: Efstratios
authors.initials: E
authors.lastname: Patsouris
authors.forename: Penelope
authors.initials: P
authors.lastname: Korkolopoulou
mesh_terms: D000328:Adult; D001254:Astrocytoma / Q000175:diagnosis* / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism; D005260:Female; D006801:Humans; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D015415:Biomarkers; D014408:Biomarkers, Tumor; D016159:Tumor Suppressor Protein p53
references.citation: Cancer Treat Rev. 2000 Feb;26(1):67-73
references.pmid: 10660492
references.citation: Anticancer Res. 2006 Mar-Apr;26(2B):1351-7
references.pmid: 16619544
references.citation: Cancer. 1997 Jul 15;80(2):242-9
references.pmid: 9217037
references.citation: Clin Neuropathol. 1997 Nov-Dec;16(6):332-6
references.pmid: 9401801
references.citation: Br J Neurosurg. 2002 Aug;16(4):335-42
references.pmid: 12389885
references.citation: Br J Neurosurg. 1998 Aug;12(4):318-24
references.pmid: 10070423
references.citation: JAMA. 1994 Jul 20;272(3):234-7
references.pmid: 8022043
references.citation: Cancer. 1999 Aug 15;86(4):672-83
references.pmid: 10440696
references.citation: Neurosurgery. 1995 Aug;37(2):246-54
references.pmid: 7477776
references.citation: APMIS. 1994 Oct;102(10):786-92
references.pmid: 7826609
references.citation: Cancer Res. 2001 Feb 1;61(3):1122-8
references.pmid: 11221842
references.citation: J Neurooncol. 1997 Oct;35(1):13-28
references.pmid: 9266437
references.citation: J Neurooncol. 2002 Jul;58(3):217-36
references.pmid: 12187957
references.citation: J Clin Pathol. 2001 Nov;54(11):860-5
references.pmid: 11684721
references.citation: J Neurosurg. 1997 Jan;86(1):121-30
references.pmid: 8988090
references.citation: Cancer. 2003 Feb 1;97(3):644-8
references.pmid: 12548606
references.citation: Neuropathol Appl Neurobiol. 1998 Oct;24(5):381-8
references.pmid: 9821169
references.citation: Clin Neuropathol. 1996 Mar-Apr;15(2):67-73
references.pmid: 8925599
references.citation: Clin Neuropathol. 1997 Jul-Aug;16(4):220-6
references.pmid: 9266149
references.citation: Eur Respir J. 2001 Oct;18(4):705-19
references.pmid: 11716177
references.citation: J Clin Oncol. 2001 Mar 15;19(6):1865-78
references.pmid: 11251019
references.citation: Clin Cancer Res. 2006 Jan 15;12(2):473-7
references.pmid: 16428489
references.citation: Br J Cancer. 1997;75(9):1269-78
references.pmid: 9155045
references.citation: Br J Cancer. 2004 Nov 1;91(9):1678-86
references.pmid: 15494720
references.citation: J Neurooncol. 2001 Dec;55(3):195-204
references.pmid: 11859975
references.citation: Acta Neuropathol. 2007 Aug;114(2):97-109
references.pmid: 17618441
references.citation: J Neurooncol. 2006 Oct;80(1):49-55
references.pmid: 16645716
references.citation: Brain Pathol. 2006 Oct;16(4):273-86
references.pmid: 17107596
references.citation: Diagn Mol Pathol. 1994 Dec;3(4):240-5
references.pmid: 7866633
references.citation: Mol Cell. 2004 Mar 26;13(6):879-86
references.pmid: 15053880
references.citation: Br J Neurosurg. 1995 Apr;9(2):143-9
references.pmid: 7632359
references.citation: J Natl Cancer Inst. 1994 Jun 1;86(11):829-35
references.pmid: 8182763
references.citation: Kaohsiung J Med Sci. 1998 Oct;14(10):607-15
references.pmid: 9819502
references.citation: Health Technol Assess. 2003;7(5):1-162
references.pmid: 12633526
references.citation: Genes Dev. 2007 Nov 1;21(21):2683-710
references.pmid: 17974913
references.citation: Cancer Res. 1994 Sep 15;54(18):4855-78
references.pmid: 8069852
references.citation: J Clin Oncol. 2004 Mar 15;22(6):975-7
references.pmid: 14981108
references.citation: Cancer. 2003 Feb 15;97(4):1063-71
references.pmid: 12569607
references.citation: Clin Cancer Res. 2002 Jan;8(1):180-7
references.pmid: 11801556
references.citation: J Neurol Neurosurg Psychiatry. 1995 Oct;59(4):413-9
references.pmid: 7561922
references.citation: J Neurooncol. 2002 Jul;58(3):203-15
references.pmid: 12187956
references.citation: Br J Cancer. 1994 Mar;69(3):586-91
references.pmid: 8123492
references.citation: Adv Cancer Res. 2000;77:81-137
references.pmid: 10549356
references.citation: Int J Cancer. 1994 Feb 1;56(3):347-53
references.pmid: 7906253
references.citation: Clin Cancer Res. 1995 Dec;1(12):1617-22
references.pmid: 9815964
references.citation: Appl Immunohistochem Mol Morphol. 2006 Mar;14(1):91-6
references.pmid: 16540738
references.citation: Arq Neuropsiquiatr. 2004 Jun;62(2A):262-70
references.pmid: 15235729
references.citation: Clin Neuropathol. 2000 Sep-Oct;19(5):230-4
references.pmid: 11048748
references.citation: Clin Cancer Res. 2002 May;8(5):1117-24
references.pmid: 12006527
references.citation: Lancet Oncol. 2005 Sep;6(9):678-86
references.pmid: 16129368
references.citation: Oncol Rep. 2002 Jul-Aug;9(4):703-7
references.pmid: 12066196
references.citation: Neuropathol Appl Neurobiol. 1999 Apr;25(2):134-42
references.pmid: 10216001
references.citation: Neurosurgery. 1998 Apr;42(4):724-9
references.pmid: 9574635
references.citation: Lancet. 1993 Feb 13;341(8842):418-22
references.pmid: 8094183
references.citation: Pediatr Neurosurg. 2005 Nov-Dec;41(6):292-9
references.pmid: 16293948
references.citation: J Neurooncol. 2006 Jun;78(2):123-7
references.pmid: 16614946
references.citation: Nat Clin Pract Urol. 2005 Aug;2(8):416-22
references.pmid: 16482653
references.citation: Crit Rev Neurosurg. 1998 Sep 14;8(5):269-74
references.pmid: 9732540
references.citation: J Pathol. 1992 Apr;166(4):329-30
references.pmid: 1517889
references.citation: Pathol Res Pract. 1998;194(12):831-6
references.pmid: 9894248
references.citation: Stat Med. 1998 Dec 30;17(24):2815-34
references.pmid: 9921604
references.citation: Nature. 2000 Nov 16;408(6810):307-10
references.pmid: 11099028
references.citation: Br J Cancer. 1992 Aug;66(2):373-85
references.pmid: 1503912
references.citation: Zentralbl Neurochir. 2003;64(1):30-6
references.pmid: 12582944
references.citation: Br J Cancer. 2004 Apr 19;90(8):1572-6
references.pmid: 15083187